Chemomab Therapeutics Ltd. (CMMB)
NASDAQ: CMMB · Real-Time Price · USD
2.760
-0.272 (-8.98%)
Sep 15, 2025, 2:16 PM EDT - Market open

Chemomab Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202018 - 2019
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
143463779-
Upgrade
Market Cap Growth
71.33%466.14%-83.65%-53.12%--
Upgrade
Enterprise Value
615-15-915-
Upgrade
Last Close Price
3.037.242.0412.8027.60-
Upgrade
PB Ratio
1.622.520.361.021.28-
Upgrade
P/TBV Ratio
1.622.520.361.021.28-
Upgrade
Debt / Equity Ratio
-0.020.020.010.010.04
Upgrade
Quick Ratio
7.324.514.155.9823.158.95
Upgrade
Current Ratio
7.424.984.326.1823.669.00
Upgrade
Return on Equity (ROE)
-120.16%-91.34%-91.02%-56.60%-34.53%-51.36%
Upgrade
Return on Assets (ROA)
-61.70%-47.10%-48.80%-33.20%-20.12%-29.12%
Upgrade
Return on Capital (ROIC)
-79.03%-58.96%-59.12%-36.30%-21.16%-31.37%
Upgrade
Earnings Yield
-75.39%-40.86%-401.76%-74.96%-15.86%-
Upgrade
FCF Yield
-91.41%-45.08%-391.69%-55.42%-16.03%-
Upgrade
Buyback Yield / Dilution
-67.27%-52.79%-3.26%-9.70%-51.71%-
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q